In sharp contrast, Li et al. and Pikatan et al. reported that silencing of BTK by siRNAs or inhibition of BTK by ibrutinib or acalabrutinib significantly reduces the proliferation and viability of human neuroblastoma cell lines (30, 83). Here, BTK is linked to neuroblastoma.